ADVERTISEMENT

Suggestions

Today's Paper
Login
Thursday, May 21, 2026
Login

Covaxin

Covaxin is safe in Phase 1 trials: Lancet

India’s first indigenous vaccine against COVID-19, Covaxin, showed enhanced immune response without any serious side effects in the participants enrolled for the phase 1 trials, according to the results published in The
Jan. 22, 2021

Covaxin has drawn global attention: ICMR

The Indian Council of Medical Research (ICMR) has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. In a tweet, the ICMR said, “India’s indigenous vaccine against #Covid19 Covaxin-a
Dec. 25, 2020
·

Follow

Newsletter